FNDC5 and chronic kidney disease: Interestingly, irisin administration significantly upregulated circulating irisin levels (Figure 2F), improved BV/TV and Tb.N, and reduced Tb.Sp and SMI, compared with femurs from vehicle-treated CKD mice (Figure 2G).